GABAA Receptor α2/α3 Subtype-Selective Modulators as Potential Nonsedating Anxiolytics (Q37838939)

24 August 2017

1 reference

title

GABAA receptor alpha2/alpha3 subtype-selective modulators as potential nonsedating anxiolytics (English)

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

24 August 2017

GABAA Receptor α2/α3 Subtype-Selective Modulators as Potential Nonsedating Anxiolytics (English)

1 reference

24 November 2024

John R. Atack

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21309116

reference URL

24 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21309116

reference URL

24 November 2024

publication date

1 January 2010

1 reference

24 August 2017

2010

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21309116

reference URL

full work available at URL

24 November 2024

http://link.springer.com/content/pdf/10.1007/7854_2009_30

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Current topics in behavioral neurosciences

24 November 2024

published in

1 reference

24 August 2017

1 reference

24 August 2017

page(s)

331-360

1 reference

The diagnosis and management of benzodiazepine dependence

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

The benzodiazepine binding site of GABA A receptors as a target for the development of novel anxiolytics

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

GABAA Receptor α2/α3 Subtype-Selective Modulators as Potential Nonsedating Anxiolytics

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Anxiogenic properties of an inverse agonist selective for alpha3 subunit-containing GABA A receptors

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors.

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates.

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

The plasma-occupancy relationship of the novel GABAA receptor benzodiazepine site ligand, alpha5IA, is similar in rats and primates

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist.

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans.

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Contributions of GABAA receptor subtype selectivity to abuse liability and dependence potential of pharmacological treatments for anxiety and sleep disorders.

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Reducing abuse liability of GABAA/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2/3 subtypes

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Pharmacology of recombinant gamma-aminobutyric acidA receptors rendered diazepam-insensitive by point-mutated alpha-subunits.

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Imidazo[1,2-a]pyrimidines as functionally selective GABA(A) ligands

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

(-)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor.

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

GABAA and GABAB receptor site distribution in the rat central nervous system

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

In vivo bidirectional modulatory effect of benzodiazepine receptor ligands on GABAergic transmission evaluated by positron emission tomography in non-human primates

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine: a functionally selective gamma-aminobutyric acid(A) (GABA(A)) alpha2/alpha3-subtype selective agonist that exhibits potent anxiolytic

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

An updated unified pharmacophore model of the benzodiazepine binding site on gamma-aminobutyric acid(a) receptors: correlation with comparative models

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Advances in biochemical psychopharmacology

24 November 2024

113

E Costa

1975

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Benzodiazepines and risk of hip fractures in older people: a review of the evidence

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition.

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Determination of medazepam (nobrium), diazepam(valium) and their major biotransformation products in blod and urine by electron capture s-liquid chromatography.

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Evidence for a significant role of alpha 3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines.

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Comparative models of GABAA receptor extracellular and transmembrane domains: important insights in pharmacology and function.

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Imidazo[1,2-a]pyrimidines as functionally selective and orally bioavailable GABA(A)alpha2/alpha3 binding site agonists for the treatment of anxiety disorders

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Advances in biochemical psychopharmacology

24 November 2024

131

W Haefely

1975

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Selective antagonists of benzodiazepines

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Imidazo[1,2-b][1,2,4]triazines as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Reversal of pathological pain through specific spinal GABAA receptor subtypes.

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Novel discriminative stimulus effects of TPA023B, subtype-selective gamma-aminobutyric-acid(A)/benzodiazepine modulator: comparisons with zolpidem, lorazepam, and TPA023

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Withdrawing Benzodiazepines in Primary Care

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Cortical inhibitory neurons and schizophrenia

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Molecular and neuronal substrate for the selective attenuation of anxiety.

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Differential behavioral effects of low efficacy positive GABAA modulators in combination with benzodiazepines and a neuroactive steroid in rhesus monkeys

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Do subtype-selective gamma-aminobutyric acid A receptor modulators have a reduced propensity to induce physical dependence in mice?

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Diazepam impairs lateral position control in highway driving

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Selective labelling of diazepam-insensitive GABAA receptors in vivo using [3H]Ro 15-4513

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

[3H]L-655,708, a novel ligand selective for the benzodiazepine site of GABAA receptors which contain the alpha 5 subunit

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

GABA-based therapeutic approaches: GABAA receptor subtype functions

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Discovery of Imidazo[1,2-b][1,2,4]triazines as GABAAα2/3 Subtype Selective Agonists for the Treatment of Anxiety

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Sequence and functional expression of the GABA A receptor shows a ligand-gated receptor super-family

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Use of benzodiazepines in anxiety disorders

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

https://api.crossref.org/works/10.1007/7854_2009_30

24 November 2024

Pharmacological Reviews

181

W Sieghart

1995

1 reference

Subunit composition, distribution and function of GABA(A) receptor subtypes

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Impact of subunit positioning on GABAA receptor function

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Analysis of the set of GABA(A) receptor genes in the human genome

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Recent advances in Cys-loop receptor structure and function

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux.

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

The mouse beam walking assay offers improved sensitivity over the mouse rotarod in determining motor coordination deficits induced by benzodiazepines

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

https://api.crossref.org/works/10.1007/7854_2009_30

24 November 2024

The benzodiazepine story

1 reference

A selective imidazobenzodiazepine antagonist of ethanol in the rat.

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

In vivo characterization and dynamic receptor occupancy imaging of TPA023B, an alpha 2/alpha 3/alpha 5 subtype selective gamma-aminobutyric acid-a partial agonist

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Pharmacokinetic and pharmacodynamic interactions of bretazenil and diazepam with alcohol

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Consequences of the 1989 New York State Triplicate Benzodiazepine Prescription Regulations

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Respiratory and sedative effects of clobazam and clonazepam in volunteers

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Current benzodiazepine issues.

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

Abuse liability of flunitrazepam

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/7854_2009_30

https://api.crossref.org/works/10.1007/7854_2009_30

24 November 2024

Pharmacological Reviews

151

JH Woods

1992

1 reference

24 November 2024

Identifiers

DOI

10.1007/7854_2009_30

0 references

1 reference